Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Sales of Property, Plant and Equipment (2022 - 2024)

Updated

Grace Therapeutics' Sales of Property, Plant and Equipment was $1,000 in fiscal Q4 2024 (quarter ended Mar 31, 2024).

Analysis

Grace Therapeutics (GRCE) Sales of Property, Plant and Equipment (2022 - 2024) Analysis & Trends

For FY2024 (ended Mar 31, 2024), Sales of Property, Plant and Equipment at Grace Therapeutics came in at $111,000.

  • The fiscal Q4 2024 figure marks the highest quarterly Sales of Property, Plant and Equipment since fiscal Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -4.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 1.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 1,000.00
Sep 30, 2022 -150,000.00
Jun 30, 2022 150,000.00
API Access

Grace Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=GRCE&period=max&api_key=YOUR_API_KEY